Tapentadol is partially metabolized through the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medications that enrich or repress the action/expression of one or more of such enzymes, in addition to with substrates of such enzymes (due to Competitors for your enzyme); some enzyme mediators/substrates need dosing ad